Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Dissociative / PCP
Dissociative

PCP

1-(1-phenylcyclohexyl)piperidine

PCP ('angel dust') is a dissociative anesthetic that can cause agitation, violent or unpredictable behavior, and dangerous medical emergencies; effects are unpredictable and risky.

Overview

PCP (phencyclidine), known on the street as 'angel dust,' is a dissociative drug originally developed as an anesthetic but abandoned for human medical use because of severe side effects. It produces a sense of detachment from reality and the body, along with distorted perceptions, and at higher doses it can cause profound disorientation, agitation, and unpredictable — sometimes violent — behavior. It comes as a powder, tablet, or liquid and is swallowed, snorted, smoked (often by dipping a cigarette or cannabis joint), or injected. PCP is considered a particularly hazardous drug because its effects are dose-dependent and unpredictable, it can cause serious psychiatric and medical emergencies, and people under its influence may be a danger to themselves or others.

Source: DEA; PubChem CID 6468

Chemistry & mechanism of action

PCP is a dissociative anesthetic that works mainly by blocking the NMDA glutamate receptor, interrupting the normal flow of information through the brain and producing the characteristic sense of detachment from one's body and surroundings, distorted perception, and, at higher doses, a trance-like or catatonic state. It also affects dopamine and other systems, which contributes to its stimulant-like agitation and its potential to produce psychosis-like states. Because the relationship between dose and effect is steep and unpredictable, relatively small differences in amount can produce very different — and far more dangerous — states. Repeated use can produce tolerance and a pattern of compulsive use in some people.

Source: PubChem CID 6468

Effects

At lower doses PCP produces a sense of detachment, euphoria or numbness, distorted perceptions of sight and sound, and a feeling of being separated from one's body, along with physical signs like a blank stare, rapid involuntary eye movements, slurred speech, and loss of coordination. As the dose rises, effects can include severe disorientation, anxiety, paranoia, hallucinations, and agitation that can escalate to aggressive or violent behavior. High doses can cause dangerously high blood pressure, very high body temperature, seizures, muscle rigidity, a catatonic state, and unconsciousness. People on PCP may have reduced sensitivity to pain, which can lead to serious injury. Effects can be prolonged and unpredictable, and some people experience lingering psychiatric effects.

Source: DEA

Risks & harms

PCP is dangerous in several distinct ways. Behaviorally, it can cause severe agitation, paranoia, and unpredictable or violent behavior, and its pain-blunting effect means people can injure themselves badly without realizing it — making it a risk to the user and to others. Medically, high doses can cause a hypertensive crisis, dangerously high body temperature, seizures, muscle breakdown (rhabdomyolysis) that can damage the kidneys, coma, and death. The dose-effect relationship is steep and unpredictable, so escalation is especially risky, and combining PCP with alcohol or other depressants increases the danger of sedation and unconsciousness. There is no specific antidote; management is emergency medical and psychiatric care, ideally in a calm, low-stimulation environment. Severe agitation, very high temperature, chest pain, seizures, or unconsciousness are medical emergencies — call 911. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use or mental-health support the SAMHSA National Helpline is 1-800-662-4357.

Source: DEA; SAMHSA

Subjective effects

distortion of sight/sound, detachment, numbness, slurred speech, loss of coordination, sense of strength/invulnerability; hallucinations at high dose

Long-term effects

impaired memory/thinking, speech difficulties, suicidal thoughts, anxiety, depression, social withdrawal; dependence + withdrawal

Onset

smoked 2–5 min / oral 30–60 min

Duration

4–8 hr

After-effects

subjective effects 24–48 hr

Harmful effects

agitation, psychosis, bizarre behavior, raised BP/HR/temp

Medicinal use

none (1950s vet anesthetic, discontinued)

History

developed 1950s as IV vet anesthetic; human trials ~1960 discontinued (postoperative delirium); peaked as abuse drug 1970s

Prevalence

NFLIS >104,000 reports since 1997 (~2,300 in 2024)

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With dissociatives, coordination and judgment are impaired and effects can come in waves — sit or lie down somewhere safe so you don't fall, and don't drive or make decisions until it clears.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
1-(1-phenylcyclohexyl)piperidinePubChem PUG-REST · retrieved 2026-06-18
SMILES
C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3PubChem PUG-REST · retrieved 2026-06-18
InChIKey
JTJMJGYZQZDUJJ-UHFFFAOYSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
angel dust, PHENCYCLIDINE, Angel dust, Fenciclidina, Phencyclidinum, Phencycline, Cl-395, Phenylcyclidine, CL 395, GP 121, Dust, AngelPubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index